Intracellular TRBC1 staining by flow cytometry is feasible and might provide useful diagnostic information in the distinction between T lymphoblastic leukemia/lymphoma and benign thymocytes, both of which are mostly negative for surface CD3/TCR complex (manuscript in preparation). This evidence concerns the gene TRBC1 and lymphoma.